Wavefront-guided Laser Assisted Subepithelial Keratectomy in Low Myopia, Myopic Astigmatism and High Myopia

To compare the safety, efficacy, predictability, stability and complications of wavefront-guided laser-assisted subepithelial keratectomy (LASEK) in low myopia, myopic astigmatism and high myopia correction. In his retrospective study, 416 eyes were divided to 3 groups: 159 eyes with low myopia (LM) and mean refractive spherical equivalent (MRSE) of -3.68±1.33 (SD) diopter (D); 161 eyes with myopic astigmatism (MA) and MRSE of -5.99±2.24 D and mean cylinder of 2.41±1.07 D; and 96 eyes with high myopia (HM) and MRSE of -7.41±0.80D. After an epithelial flap creation, a Wavefront-based excimer laser ablation was performed. Safety, efficacy, predictability, and stability were evaluated at day 10, months 2, 6 and 12 postoperatively. The MRSE were -0.36±0.31 D in LM group, 0.15±0.41 D in MA group and 0.58±0.68 D in HM group. The uncorrected visual acuity (UCVA) were 20/20 in 90.60% of patients in LM group, 78.90% in MA group and 67% in HM group. Efficacy indices were 0.98, 1.04 and 0.92 in LM, MA and HM groups, respectively. Safety indices were 1.00, 1.07 and 1.05 in LM, MA and HM respectively. Five eyes (3.1%) in the LM group improved 1 line. Forty-four eyes (27.3%) in MA gained 1-3 lines and 19.2 % of HM group gained 1-2 lines of BSCVA. Only 2 eyes in LM group developed corneal haze. There were not significant statistically differences in efficacy and safety indices between three groups. Wavefront-guided LASEK is an effective and safe procedure for the treatment of LM, MA, and HM. Although predictability, efficacy and safety indices improved in myopic astigmatism.